Dolutegravir-based regimen may lead to significant improvement in lipids blood concentration, but relevant increases in trunk fat without alterations of body mass index.
Individuals with novel coronavirus disease 2019 who have familial hypercholesterolemia may be at higher risk for cardiac complications and atherosclerotic cardiovascular disease in the long-term.
The increase in incidence of T1DM may not be solely a result of genetics and environmental factors, but also that of gut microbiota.
The study, presented at the American Society for Bone and Mineral Research 2019 Annual Meeting, described the experience of patients who initiated treatment with abaloparatide.
Fatty liver index is a useful and simple clinical biomarker to identify individuals at risk of developing type 2 diabetes.
